Jaiswal Shradha G, Gadbail Amol R, Chaudhary Minal S, Jaiswal Gagan R, Gawande Madhuri
Department of Oral and Maxillofacial Pathology and Microbiology, Sri Aurobindo Dental College, Indore (M.P.), India.
Quintessence Int. 2011 Oct;42(9):771-9.
This study aimed to assess the serum levels of vascular endothelial growth factor in oral squamous cell carcinoma patients before and after surgical therapy, to compare these values with those of healthy individuals using ELISA, and to evaluate if any correlation existed between vascular endothelial growth factor levels and TNM stage or histolopathologic grade of the tumor.
The study included three groups: group A1 consisted of 31 oral squamous cell carcinoma patients who had not received any prior treatment; group A2 consisted of the same 31 oral squamous cell carcinoma patients who had undergone radical surgical excision 1 month prior but no adjuvant therapy; and group B (control group) consisted of 16 healthy individuals. The serum vascular endothelial growth factor levels were assessed using the ELISA kit.
The vascular endothelial growth factor levels of preoperative oral squamous cell carcinoma patients were found to be three times higher than those of controls, and this difference was found to be statistically significant. The postoperative vascular endothelial growth factor levels had decreased 1 month after surgery but did not decrease to baseline levels. The vascular endothelial growth factor levels increased progressively with the TNM stage and histologic grade of tumor, but no definite correlation between the two could be found.
Vascular endothelial growth factor is an important marker of angiogenesis, as the vascular endothelial growth factor levels of the oral squamous cell carcinoma groups remained significantly elevated compared to that of controls. Though no significant difference was found between the pre- and postoperative oral squamous cell carcinoma groups, it can be suggested that successful treatment may reduce serum vascular endothelial growth factor levels if the time period of postoperative sample collection is increased. Only then can the utility of vascular endothelial growth factor as marker for assessing the effectiveness of surgical therapy or as a prognostic indicator be commented upon.
本研究旨在评估口腔鳞状细胞癌患者手术治疗前后血清血管内皮生长因子水平,采用酶联免疫吸附测定法(ELISA)将这些值与健康个体的值进行比较,并评估血管内皮生长因子水平与肿瘤的TNM分期或组织病理学分级之间是否存在相关性。
本研究包括三组:A1组由31例未接受过任何先前治疗的口腔鳞状细胞癌患者组成;A2组由同样的31例口腔鳞状细胞癌患者组成,这些患者在1个月前接受了根治性手术切除但未接受辅助治疗;B组(对照组)由16名健康个体组成。使用ELISA试剂盒评估血清血管内皮生长因子水平。
发现术前口腔鳞状细胞癌患者的血管内皮生长因子水平比对照组高3倍,且这种差异具有统计学意义。术后1个月血管内皮生长因子水平有所下降,但未降至基线水平。血管内皮生长因子水平随肿瘤的TNM分期和组织学分级逐渐升高,但两者之间未发现明确的相关性。
血管内皮生长因子是血管生成的重要标志物,因为与对照组相比,口腔鳞状细胞癌组的血管内皮生长因子水平仍显著升高。尽管术前和术后口腔鳞状细胞癌组之间未发现显著差异,但可以认为,如果增加术后样本采集的时间段,成功的治疗可能会降低血清血管内皮生长因子水平。只有到那时,才能对血管内皮生长因子作为评估手术治疗效果的标志物或预后指标的效用进行评价。